Rezolute, Inc. announced that the FDA has lifted the partial clinical holds on its drug RZ358 for treating hypoglycemia due to congenital hyperinsulinism.
AI Assistant
REZOLUTE INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.